Precision medicine approach to coronary artery disease: Haptoglobin phenotype‑guided risk assessment
Molecular Medicine Reports · 12.03.2026 · 33 (5) · 1-9
DOI: 10.3892/mmr.2026.13844 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Medicine Reports, online erschienen am 12.03.2026. Verfasst von Zhengxin He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Basic Medicine, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China. Hauptthemen laut MEDLINE: Haptoglobins, Coronary Artery Disease, Precision Medicine. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Basic Medicine, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China.
- Department of Ultrasonography, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China.
- Department of Laboratory Medicine, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China.
Zitieren
APA
He, Z., Liu, H., Jia, K., Lei, D., An, L., Wang, J., & Wang, F. (2026). Precision medicine approach to coronary artery disease: Haptoglobin phenotype‑guided risk assessment. Molecular Medicine Reports, 33(5), 1-9. https://doi.org/10.3892/mmr.2026.13844
Vancouver
He Z, Liu H, Jia K, Lei D, An L, Wang J, et al. Precision medicine approach to coronary artery disease: Haptoglobin phenotype‑guided risk assessment. Molecular Medicine Reports. 2026;33(5):1-9. doi:10.3892/mmr.2026.13844
BibTeX
@article{He2026,
author = {He, Zhengxin and Liu, Hong and Jia, Keran and Lei, Daxin and An, Liyun and Wang, Jia and Wang, Fukun},
title = {Precision medicine approach to coronary artery disease: Haptoglobin phenotype‑guided risk assessment},
journal = {Molecular Medicine Reports},
year = {2026},
volume = {33},
number = {5},
pages = {1--9},
doi = {10.3892/mmr.2026.13844}
}
EUVIMED